Ligand Pharmaceuticals Statistics
Total Valuation
KWSE:TAHSSILAT has a market cap or net worth of KWD 41.91 million. The enterprise value is 41.67 million.
Market Cap | 41.91M |
Enterprise Value | 41.67M |
Important Dates
The last earnings date was Monday, August 4, 2025.
Earnings Date | Aug 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KWSE:TAHSSILAT has 165.00 million shares outstanding.
Current Share Class | 165.00M |
Shares Outstanding | 165.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 10.74M |
Valuation Ratios
The trailing PE ratio is 841.30.
PE Ratio | 841.30 |
Forward PE | n/a |
PS Ratio | 146.24 |
PB Ratio | 8.33 |
P/TBV Ratio | 8.35 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 836.45 |
EV / Sales | 145.40 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -1,229.30 |
Financial Position
The company has a current ratio of 3.73
Current Ratio | 3.73 |
Quick Ratio | 3.73 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.04% and return on invested capital (ROIC) is 0.01%.
Return on Equity (ROE) | 1.04% |
Return on Assets (ROA) | 0.01% |
Return on Invested Capital (ROIC) | 0.01% |
Return on Capital Employed (ROCE) | 0.02% |
Revenue Per Employee | 8,956 |
Profits Per Employee | 1,557 |
Employee Count | 32 |
Asset Turnover | 0.06 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +504.65% in the last 52 weeks. The beta is 1.21, so KWSE:TAHSSILAT's price volatility has been higher than the market average.
Beta (5Y) | 1.21 |
52-Week Price Change | +504.65% |
50-Day Moving Average | 0.17 |
200-Day Moving Average | 0.08 |
Relative Strength Index (RSI) | 54.87 |
Average Volume (20 Days) | 2,924,434 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KWSE:TAHSSILAT had revenue of KWD 286,582 and earned 49,816 in profits. Earnings per share was 0.00.
Revenue | 286,582 |
Gross Profit | 286,582 |
Operating Income | 959 |
Pretax Income | 51,857 |
Net Income | 49,816 |
EBITDA | 1,424 |
EBIT | 959 |
Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 256,806 in cash and n/a in debt, giving a net cash position of 256,806 or 0.00 per share.
Cash & Cash Equivalents | 256,806 |
Total Debt | n/a |
Net Cash | 256,806 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 5.03M |
Book Value Per Share | 0.03 |
Working Capital | 308,420 |
Cash Flow
In the last 12 months, operating cash flow was -32,183 and capital expenditures -1,713, giving a free cash flow of -33,896.
Operating Cash Flow | -32,183 |
Capital Expenditures | -1,713 |
Free Cash Flow | -33,896 |
FCF Per Share | -0.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of 0.33% and 17.38%.
Gross Margin | 100.00% |
Operating Margin | 0.33% |
Pretax Margin | 18.10% |
Profit Margin | 17.38% |
EBITDA Margin | 0.50% |
EBIT Margin | 0.33% |
FCF Margin | n/a |
Dividends & Yields
KWSE:TAHSSILAT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 0.12% |
FCF Yield | -0.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on March 28, 2007. It was a forward split with a ratio of 1.1.
Last Split Date | Mar 28, 2007 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |